Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H, Gabazza EC, Taguchi O, Nishii Y, Nakahara H, Bruno NE, D'Alessandro-Gabazza CN, Kasper M, Yano Y, Nagashima M, Morser J, Broze GJ, Suzuki K, Adachi Y.
Fujimoto H, et al. Among authors: nagashima m.
Am J Pathol. 2006 Apr;168(4):1086-96. doi: 10.2353/ajpath.2006.050610.
Am J Pathol. 2006.
PMID: 16565485
Free PMC article.